TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Artrya Limited ( (AU:AYA) ) is now available.
Artrya Limited has announced the application for quotation of 100,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AYA. This move signifies a strategic step in enhancing the company’s capital structure, potentially impacting its market positioning and providing new opportunities for stakeholders.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing and providing advanced medical imaging solutions. The company’s primary product offerings include innovative diagnostic tools aimed at improving the detection and management of cardiovascular diseases, with a market focus on enhancing patient outcomes through technological advancements.
Average Trading Volume: 948,416
Technical Sentiment Signal: Buy
Current Market Cap: A$513.4M
Learn more about AYA stock on TipRanks’ Stock Analysis page.